Tu Van Dao

2.8k total citations · 1 hit paper
36 papers, 539 citations indexed

About

Tu Van Dao is a scholar working on Oncology, Electrical and Electronic Engineering and Control and Systems Engineering. According to data from OpenAlex, Tu Van Dao has authored 36 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Electrical and Electronic Engineering and 9 papers in Control and Systems Engineering. Recurrent topics in Tu Van Dao's work include Microgrid Control and Optimization (8 papers), Smart Grid Energy Management (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Tu Van Dao is often cited by papers focused on Microgrid Control and Optimization (8 papers), Smart Grid Energy Management (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Tu Van Dao collaborates with scholars based in Vietnam, Japan and United States. Tu Van Dao's co-authors include Yasuhiro Hayashi, Hideo Ishii, В. В. Бредер, Lorenza Rimassa, George Lau, Bruno Sangro, Alejandra Negro, Kabir Mody, Ghassan K. Abou‐Alfa and Alexander Vasilyev and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Tu Van Dao

31 papers receiving 532 citations

Hit Papers

Phase 3 randomized, open-label, multicenter study of trem... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.
    2022 259 citations Ghassan K. Abou‐Alfa, Masatoshi Kudo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tu Van Dao Vietnam 10 238 206 134 115 94 36 539
Chunlin Jiang China 14 83 0.3× 222 1.1× 45 0.3× 194 1.7× 90 1.0× 23 529
Zihao Dai China 12 164 0.7× 113 0.5× 94 0.7× 595 5.2× 86 0.9× 23 857
Kai Lei China 7 128 0.5× 81 0.4× 58 0.4× 274 2.4× 56 0.6× 21 493
Juan A. Santamaria‐Barria United States 10 294 1.2× 97 0.5× 114 0.9× 80 0.7× 94 1.0× 33 575
Shaolong Li China 13 218 0.9× 357 1.7× 130 1.0× 141 1.2× 181 1.9× 24 768
Fatiha Merabtene France 11 189 0.8× 77 0.4× 86 0.6× 166 1.4× 184 2.0× 20 509
Sirui Fu China 14 95 0.4× 231 1.1× 77 0.6× 191 1.7× 78 0.8× 29 530
Xingxing Qi China 9 259 1.1× 133 0.6× 35 0.3× 111 1.0× 52 0.6× 11 466
Yongqian Shu China 10 179 0.8× 13 0.1× 110 0.8× 99 0.9× 64 0.7× 31 407
Alessio Fabozzi Italy 13 264 1.1× 52 0.3× 108 0.8× 221 1.9× 63 0.7× 32 507

Countries citing papers authored by Tu Van Dao

Since Specialization
Citations

This map shows the geographic impact of Tu Van Dao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tu Van Dao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tu Van Dao more than expected).

Fields of papers citing papers by Tu Van Dao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tu Van Dao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tu Van Dao. The network helps show where Tu Van Dao may publish in the future.

Co-authorship network of co-authors of Tu Van Dao

This figure shows the co-authorship network connecting the top 25 collaborators of Tu Van Dao. A scholar is included among the top collaborators of Tu Van Dao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tu Van Dao. Tu Van Dao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dao, Tu Van, Nitesh Nerlekar, Stephen J. Nicholls, & Kristen J. Bubb. (2025). The effectiveness of intervention with omega-3 fatty acids, eicosapentaenoic and docosahexenoic acid in peripheral arterial disease: a systematic review and meta-analysis. Nutrition Metabolism and Cardiovascular Diseases. 36(1). 104286–104286.
3.
4.
5.
Nguyen, Chu Van, et al.. (2024). Intra thyroid thymic carcinoma: A case report and literature review. International Journal of Surgery Case Reports. 119. 109762–109762.
6.
7.
Sangro, Bruno, George Lau, Masatoshi Kudo, et al.. (2023). 147P Four-year overall survival (OS) update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (uHCC). Annals of Oncology. 34. S1530–S1531. 1 indexed citations
8.
Dao, Tu Van, et al.. (2022). Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis. European Urology. 81(4). 349–361. 72 indexed citations
9.
Dao, Tu Van, et al.. (2022). Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III Non-Small-Cell Lung Cancer: Results of KINDLE-Vietnam Cohort. Frontiers in Oncology. 12. 842296–842296. 2 indexed citations
10.
Trần, Hương Thanh, Sang M. Nguyen, Tu Van Dao, et al.. (2022). Menstrual and Reproductive Factors in Association With Breast Cancer Risk in Vietnamese Women: A Case-Control Study. Cancer Control. 29. 2905558254–2905558254. 3 indexed citations
11.
Tran, Thuan V., et al.. (2021). Risk factors of Pancreatic Cancer in Vietnam: A Matched Case–Control Hospital-Based Study. Cancer Control. 28. 1149424584–1149424584. 4 indexed citations
12.
Dao, Tu Van, et al.. (2020). Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam. Cancer Control. 27(1). 1148404147–1148404147. 14 indexed citations
13.
Dao, Tu Van, et al.. (2020). B10 Prevalence of EGFR Mutation Among Vietnamese Non-Small Cell Lung Cancer: A Preliminary Study. Journal of Thoracic Oncology. 15(2). S30–S30. 1 indexed citations
14.
Yabe, Kuniaki, et al.. (2019). Spinning reserve quantification considering confidence levels of forecast in systems with high wind and solar power penetration. IEEJ Transactions on Electrical and Electronic Engineering. 14(9). 1304–1313. 5 indexed citations
15.
Dao, Tu Van, Hideo Ishii, & Yasuhiro Hayashi. (2018). HEMS Operation with Utility Requirements for Rooftop Solar-Battery Systems. 6. 1–5. 1 indexed citations
16.
Dao, Tu Van, et al.. (2018). Optimal Responses of Home Energy Management Systems to Aggregator and Utility Requirements. 616–621. 1 indexed citations
17.
Sánchez-Díaz, Patricia C., et al.. (2017). Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is associated with stem-like cancer cell functions in pediatric high-grade glioma. PLoS ONE. 12(5). e0176879–e0176879. 27 indexed citations
18.
Dao, Tu Van, Hideo Ishii, & Yasuhiro Hayashi. (2017). Optimal smart functions of large-scale PV inverters in distribution systems. 1–7. 15 indexed citations
19.
Dao, Tu Van, Thuan V. Tran, Christophe Lebœuf, et al.. (2016). Sorafenib Acts through VEGFR-2 Inhibition in a Metastatic Clear-Cell Sarcoma of the Kidney. Journal of Cancer Therapy. 7(7). 487–493.
20.
Dao, Tu Van, et al.. (2014). An approach to online asynchronous mode prevention in two-area power systems. 2. 1–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunlin Jiang Breakdown of academic impact, for papers by Zihao Dai Breakdown of academic impact, for papers by Kai Lei Breakdown of academic impact, for papers by Juan A. Santamaria‐Barria Breakdown of academic impact, for papers by Shaolong Li Breakdown of academic impact, for papers by Fatiha Merabtene Breakdown of academic impact, for papers by Sirui Fu Breakdown of academic impact, for papers by Xingxing Qi Breakdown of academic impact, for papers by Yongqian Shu Breakdown of academic impact, for papers by Alessio Fabozzi
Rankless by CCL
2026